Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

87 та иш

Иш: Identification of Phytochemicals as Promising GSK-3β Inhibitors for Cancer Therapeutic Potential Through Virtual Screening, Molecular Docking, MD Simulation and MM-PBSA Calculation

  1. 7,8‐dihydroxyflavone Ameliorates Motor Deficits Via Suppressing <i>α</i> ‐synuclein Expression and Oxidative Stress in the <scp>MPTP</scp> ‐induced Mouse Model of Parkinson's Disease

    Xiaohuan Li, Chunfang Dai, Long Chen +3

    Мақола20162 иқтибос
    ABI

  2. Diosmin reduces cerebral Aβ levels, tau hyperphosphorylation, neuroinflammation, and cognitive impairment in the 3xTg-AD mice

    Darrell Sawmiller, Ahsan Habib, Song Li +8

    Мақола20162 иқтибос
    ABI

  3. Protective Effects of Flavonoids against Alzheimer’s Disease: Pathological Hypothesis, Potential Targets, and Structure–Activity Relationship

    Jiao Li, Min Sun, Xiaodong Cui +1

    Шарҳ мақола20222 иқтибос
    ABI

  4. Evaluation of Expression of Cytochrome P450 Aromatase and Inflammatory, Oxidative, and Apoptotic Markers in Testicular Tissue of Obese Rats (Pre)Treated with Garlic Powder

    Li Baicheng, Jia Li, Abolfazl Akbari +2

    Мақола20232 иқтибос
    ABI

  5. Computational insight into in silico analysis and molecular dynamics simulation of the dimer interface residues of ALS-linked hSOD1 forms in apo/holo states: a combined experimental and bioinformatic perspective

    Hamza Dakhil Zaji, Bagher Seyedalipour, Haider Munzer Hanun +3

    Мақола20232 иқтибос
    ABI

  6. The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma

    Nasim Ebrahimi, Nazanin Pazhouhesh Far, Siavash Seifollahy Fakhr +11

    Шарҳ мақола20232 иқтибос
    ABI

  7. Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients’ susceptibility to COVID-19 to the possible caution of future global diabetes tsunami

    Yasamin Sharbatdar, Ronak Mousavian, Seyed Mostafa Noorbakhsh Varnosfaderani +9

    Шарҳ мақола20232 иқтибос
    ABI

  8. Polyphenolic flavonoid compounds act as the inhibitory potential of aggregation process: Implications for the prevention and therapeutics against FALS-associated D101G SOD1 mutant

    Hussein maitham Qassim, Bagher Seyedalipour, Payam Baziyar +1

    Мақола20232 иқтибос
    ABI

  9. Fighting against amyotrophic lateral sclerosis (ALS) with flavonoids: a computational approach to inhibit superoxide dismutase (SOD1) mutant aggregation

    Seyed Mostafa Noorbakhsh Varnosfaderani, Melika Sadat Haeri, Ali Sam Arian +7

    Мақола20232 иқтибос
    ABI

  10. Mutation/metal deficiency in the "electrostatic loop" enhanced aggregation process in apo/holo SOD1 variants: implications for ALS diseases

    Faezeh Ashkaran, Bagher Seyedalipour, Payam Baziyar +1

    Мақола20242 иқтибос
    ABI

  11. Discovering the therapeutic potential of Naringenin in diabetes related to GLUT-4 and its regulatory factors: A computational approach

    Ali Khakpour, Shamim Ghiabi, Ali Kazemi Babaheydari +4

    Мақола20242 иқтибос
    ABI

  12. Crystal Structure of Glycogen Synthase Kinase 3β

    Rana Dajani, Elizabeth Fraser, S. Mark Roe +4

    Мақола20012 иқтибос
    ABI

  13. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  14. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  15. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  16. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  17. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  18. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  19. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  20. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  21. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  22. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  23. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  24. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  25. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI